Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma.

Genome Med · 2025 · PMC12619402 · PMID 41239365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Its clinical implications may be significant, allowing customized treatment plans, enhancing prognostic evaluations, and directing the creation of targeted therapeutic agents.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.